Markets
On this episode of Stock Movers: - Moderna (MRNA) shares are gaining after the vaccinemaker boosted its revenue growth guidance for the full year. The firm also posted revenue for the third quarter that beat the average analyst estimate.
Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.
On this episode of Stock Movers: - Moderna (MRNA) shares are gaining after the vaccinemaker boosted its revenue growth guidance for the full year. The firm also posted revenue for the third quarter that beat the average analyst estimate.
Read original reporting ↗No additional matched coverage has been archived for this story yet.
This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →